Return to content in this issue

Adyuvant Use of Omalizumab in Desensitization to Chemotherapeutics: Beyond IgE-Mediated Reactions

Prieto-García A^1,2, Rojas-Pérez-Ezquerra P^1,2, Noguerado-Mellado B^1,2, Zambrano G^1,2, Cuevas C^1,2, Juárez A^1,2, Tornero-Molina P<sup>1,2

1</sup>Allergy Department, University Hospital Gregorio Marañón, Madrid, Spain
²Institute for Health Research Gregorio Marañón, Madrid, Spain

J Investig Allergol Clin Immunol 2023; Vol 33(6) : 497-499
doi: 10.18176/jiaci.0911

• Abstract
• Supplemental Materials

Key words: Drug allergy, Drug desensitization, Chemotherapeutics, Omalizumab, Premedication

	Title	Type	Size
	doi10.18176_jiaci.0911_supplemental-materials-table.pdf	pdf	117.11 Kb